期刊文献+

Crimean-Congo Hemorrhagic Fever: An Overview 被引量:1

Crimean-Congo Hemorrhagic Fever: An Overview
下载PDF
导出
摘要 Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that is a serious threat to humans. The disease is widely distributed in Africa, Asia, and Europe and has developed into a serious public health concern. Humans become infected through the bites of ticks, by contact with a patient with CCHF, or by contact with blood or tissues from viremic livestock. Microvascular instability and impaired hemostasis are the hallmarks of the infection. Infection in human begins with nonspecific febrile symptoms, but may progress to a serious hemorrhagic syndrome with high mortality rates. Enzyme-linked immunoassay (ELISA) and polymerase chain reaction (PCR) are the most used and specific tests for the diagnosis. The mainstay of treatment is supportive. Although definitive studies are not available, ribavirin is suggested to be effective especially at the earlier phase of the infection. Uses of universal protective measures are the best way to avoid the infection. In this review, all aspects of CCHF are overviewed in light of the current literature. Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that is a serious threat to humans. The disease is widely distributed in Africa, Asia, and Europe and has developed into a serious public health concern. Humans become infected through the bites of ticks, by contact with a patient with CCHF, or by contact with blood or tissues from viremic livestock. Microvascular instability and impaired hemostasis are the hallmarks of the infection. Infection in human begins with nonspecific febrile symptoms, but may progress to a serious hemorrhagic syndrome with high mortality rates. Enzyme-linked immunoassay (ELISA) and polymerase chain reaction (PCR) are the most used and specific tests for the diagnosis. The mainstay of treatment is supportive. Although definitive studies are not available, ribavirin is suggested to be effective especially at the earlier phase of the infection. Uses of universal protective measures are the best way to avoid the infection. In this review, all aspects of CCHF are overviewed in light of the current literature.
出处 《Virologica Sinica》 SCIE CAS CSCD 2013年第4期193-201,共9页 中国病毒学(英文版)
关键词 出血 刚果 病毒感染 公共卫生问题 人类感染 聚合酶链反应 酶联免疫分析 ELISA Crimean-Congo Hemorrhagic Fever Epidemiology Transmission Pathogenesis Diagnosis Treatment Prevention
  • 相关文献

参考文献72

  • 1Anagnostou V, and Papa A. 2009. Evolution of Crimean-Congo Hemorrhagic Fever virus. Infect Genet Evol, 9: 948-954.
  • 2Appannanavar S B, and Mishra B. 2011. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis, 3: 285-292.
  • 3Ascioglu S, Leblebicioglu H, Vahaboglu H, and Chan K A. 2011. Ribavirin for patients with Crimean-Congo haemorrhagie fever: a systematic review and meta-analysis. J Antimicrob Chemother, 66 1215-1222.
  • 4Atkinson B, Chamberlain J, Logue C H, Cook N, Bruce C, Dowall S D, and Hewson R. 2012. Development of a real-time rt-PCR assay for the detection of crimean-congo hemorrhagic Fever virus. Vector Borne Zoonotic Dis, 12: 786-793.
  • 5Bajpai S, and Nadkar M . 2011. Crimean Congo hemorrhagic fever: requires vigilance and not panic. J Assoc Physicians India, 59: 164-167.
  • 6Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran M A, a Vahaboglu H. 2005. Crimean-Congo haemorrhagie fever outbre1 in Middle Anatolia: a multicentre study of clinical features a outcome measures. J Med Microbiol, 54: 385-389. /.
  • 7Bakir M, Engin A, Gozel M G, Elaldi N, Kilickap S, and Cinar Z. 2012. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis, 49: 105-110.
  • 8Bangash S A, and Khan E A. 2003. Treatment and prophylaxis wit ribavirin for Crimean-Congo Hemorrhagic Fever--is it effective?I J Pak Med Assoc, 53: 39-41. J.
  • 9Bente D A, Alimonti J B, Shieh W J, Camus G, Stroher U, Zaki S, and Jones S M. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol, 84: 11089-11100.
  • 10Bodur H, Akinci E, Ascioglu S, Onguru P, and Uyar Y. 2012I / Subclinical infections with Crimean-Congo hemorrhagic feve / virus, Turkey. Emerg Infect Dis, 18: 640-642.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部